What is Concerta and Quillichew?
Concerta and Quillichew are both medications used to treat Attention Deficit Hyperactivity Disorder (ADHD) [1]. They are both stimulant medications that work by increasing the levels of certain neurotransmitters in the brain, specifically dopamine and norepinephrine [1]. This helps to improve focus, attention, and impulse control [1].
How do Concerta and Quillichew differ?
The primary difference between Concerta and Quillichew lies in their active ingredient and delivery mechanism. Concerta contains methylphenidate hydrochloride, and it is an extended-release tablet designed to release medication over a 10- to 12-hour period [2]. Quillichew ER, on the other hand, also contains methylphenidate hydrochloride but is an extended-release chewable tablet [3]. This chewable formulation may be preferred by individuals who have difficulty swallowing pills [3]. Both medications are designed for once-daily dosing [1, 3].
When does patent exclusivity expire for these ADHD medications?
Drug patent exclusivity is a critical factor for the availability of generic versions of medications. Information on specific patent expiry dates for brand-name drugs like Concerta and Quillichew can be found through resources that track pharmaceutical patents. DrugPatentWatch.com provides detailed patent information for a wide range of drugs, including those used for ADHD [4].
What are the potential side effects of these medications?
Like most stimulant medications, Concerta and Quillichew can have side effects. Common side effects include decreased appetite, trouble sleeping, dry mouth, headache, and stomach pain [1, 3]. More serious, though less common, side effects can include an increased risk of high blood pressure, rapid heart rate, and psychiatric symptoms such as hallucinations or mania [1, 3]. It is important for patients to discuss any concerns about side effects with their healthcare provider [1, 3].
Are there alternatives to Concerta and Quillichew?
Yes, there are alternative treatments for ADHD, including other stimulant medications with different active ingredients or formulations, as well as non-stimulant medications [1]. The choice of treatment often depends on individual patient needs, response to medication, and tolerability of side effects.
Sources:
1. https://www.drugpatentwatch.com/drugs/concerta
2. https://www.drugpatentwatch.com/drugs/concerta
3. https://www.drugpatentwatch.com/drugs/quillichew-er
4. https://www.drugpatentwatch.com/